Elanco Animal Health
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -20.7% | -98.7% | +9,900.0% | -19.0% | +9.3% | -102.3% | – | -7.6% | -50.7% | -88.0% | +2,030.8% | – | |
| – | -1.2% | -2.9% | -2.4% | +4.9% | -3.5% | -1.8% | +5.0% | +4.1% | -1.1% | -1.1% | -0.6% | – | |
| – | +50.0% | -26.7% | +27.3% | +7.1% | +0.0% | +0.0% | +33.3% | -15.0% | -5.9% | +31.3% | -4.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +440.7% | -221.2% | – | +604.5% | -116.8% | – | – | -555.8% | – | -216.9% | – | – | |
| – | +24.2% | -41.5% | +41.7% | +23.5% | +26.2% | +22.6% | -12.3% | +61.4% | -32.6% | -17.7% | -35.3% | – | |
| – | -2.8% | – | -189.2% | – | -107.2% | -35.6% | -3.4% | +80.4% | -36.6% | -6.3% | +83.3% | – | |
| – | – | – | – | – | – | – | -92.3% | – | – | – | – | – | |
| – | – | – | – | – | -97.1% | – | -719.4% | -57.8% | -99.5% | +1,500.0% | +356.3% | – | |
| – | -11.5% | -80.6% | +244.4% | +1,340.9% | -97.6% | – | -400.0% | -1.9% | -88.2% | +261.1% | +13.8% | – | |
| – | -950.0% | – | – | +4.2% | -129.7% | – | +173.7% | -165.4% | – | -392.5% | – | – | |
| – | -29.7% | -119.0% | – | -27.7% | +3.3% | -155.6% | – | -29.4% | -63.8% | -182.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.